Idazoxan extended release (Terran Biosciences) | Interleukin Related interleukin-related.com

Product Name :
Idazoxan extended release (Terran Biosciences)

Search keywords :
Idazoxan

drugId :
null

Target Vo:
Adrenergic receptors alpha-2

Target Vo Short Name :
ADRA2

Moa_Name:
Adrenergic receptors alpha-2 antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Terran Biosciences Inc

Active Company_Name :
Terran Biosciences Australia Pty Ltd

Active Indication_Name:

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 1 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Foralumab Biological Activity
HDAC1 Rabbit mAb manufacturer
DRP1 Antibody: DRP1 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 82 kDa, targeting to DRP1. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts